198 related articles for article (PubMed ID: 18395255)
1. Oligodeoxynucleotides containing CpG motifs (CpG-ODN) predominantly induce Th1-type immune response in neonatal chicks.
Patel BA; Gomis S; Dar A; Willson PJ; Babiuk LA; Potter A; Mutwiri G; Tikoo SK
Dev Comp Immunol; 2008; 32(9):1041-9. PubMed ID: 18395255
[TBL] [Abstract][Full Text] [Related]
2. Cytosine-phosphate-guanine motifs fail to promote T-helper type 1-polarized responses in human neonatal mononuclear cells.
Prescott SL; Irwin S; Taylor A; Roper J; Dunstan J; Upham JW; Burgner D; Richmond P
Clin Exp Allergy; 2005 Mar; 35(3):358-66. PubMed ID: 15784116
[TBL] [Abstract][Full Text] [Related]
3. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice.
Inoue J; Yotsumoto S; Sakamoto T; Tsuchiya S; Aramaki Y
J Control Release; 2005 Nov; 108(2-3):294-305. PubMed ID: 16209897
[TBL] [Abstract][Full Text] [Related]
4. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.
Obermeier F; Dunger N; Deml L; Herfarth H; Schölmerich J; Falk W
Eur J Immunol; 2002 Jul; 32(7):2084-92. PubMed ID: 12115630
[TBL] [Abstract][Full Text] [Related]
5. Synthetic CpG-ODN rapidly enriches immune compartments in neonatal chicks to induce protective immunity against bacterial infections.
Gunawardana T; Ahmed KA; Goonewardene K; Popowich S; Kurukulasuriya S; Karunarathna R; Gupta A; Lockerbie B; Foldvari M; Tikoo SK; Willson P; Gomis S
Sci Rep; 2019 Jan; 9(1):341. PubMed ID: 30674918
[TBL] [Abstract][Full Text] [Related]
6. Co-stimulation with TLR3 and TLR21 ligands synergistically up-regulates Th1-cytokine IFN-γ and regulatory cytokine IL-10 expression in chicken monocytes.
He H; Genovese KJ; Swaggerty CL; MacKinnon KM; Kogut MH
Dev Comp Immunol; 2012 Apr; 36(4):756-60. PubMed ID: 22120532
[TBL] [Abstract][Full Text] [Related]
7. [A study on the mechanisms of mycobacterial clearance induced by CpG-oligodeoxynucleotides in mice].
Ren T; Liang YJ; Cai YY; Li CY; Mei J; Yuan ZH; Tao MF; Tian M; Zhao B
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jan; 31(1):46-50. PubMed ID: 18366907
[TBL] [Abstract][Full Text] [Related]
8. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
Bleich A; Janus LM; Smoczek A; Westendorf AM; Strauch U; Mähler M; Hedrich HJ; Fichtner-Feigl S; Schölmerich J; Falk W; Hofmann C; Obermeier F
Gastroenterology; 2009 Jan; 136(1):278-87. PubMed ID: 18952084
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
Wattrang E; Berg M; Magnusson M
Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
[TBL] [Abstract][Full Text] [Related]
10. Role of Hsp90 in CpG ODN mediated immunostimulation in avian macrophages.
Bhat A; Gomis S; Potter A; Tikoo SK
Mol Immunol; 2010 Mar; 47(6):1337-46. PubMed ID: 20096933
[TBL] [Abstract][Full Text] [Related]
11. Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice.
Matheu V; Treschow A; Teige I; Navikas V; Issazadeh-Navikas S
Respir Res; 2005 Mar; 6(1):25. PubMed ID: 15748290
[TBL] [Abstract][Full Text] [Related]
12. Co-administration of CpG oligonucleotides and chenopodium album extract reverse IgG2a/IgG1 ratios and increase IFN-gamma and IL-10 productions in a murine model of asthma.
Mousavi T; Salek Moghadam A; Falak R; Tebyanian M
Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):1-6. PubMed ID: 18322305
[TBL] [Abstract][Full Text] [Related]
13. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic effects and mechanisms of CpG oligodeoxynucleotides in mice infected with Mycobacterium tuberculosis].
Ren T; Li CY; Cai YY; Jin ML; Hu YW; Yuan ZH; Tian M; Zhao B
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):87-91. PubMed ID: 16677448
[TBL] [Abstract][Full Text] [Related]
15. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway.
Xu W; Tamura T; Takatsu K
Int Immunopharmacol; 2008 Feb; 8(2):351-61. PubMed ID: 18182251
[TBL] [Abstract][Full Text] [Related]
16. CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice.
Ribeiro DP; Freitas MM; Cardoso MR; Pajuaba AC; Silva NM; Mineo TW; Silva JS; Mineo JR; Silva DA
Vaccine; 2009 Apr; 27(19):2570-9. PubMed ID: 19428863
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis.
Amaral CC; Garcia IP; Fernandes GF; Almeida SR; Camargo ZP; Souza MC
Scand J Immunol; 2005 Oct; 62(4):325-33. PubMed ID: 16253119
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effect of cytosine-phosphate-guanosine (CpG)-oligonucleotides in nonasthmatic chronic rhinosinusitis: an explant model.
Tan L; Rogers TJ; Hatzirodos N; Baker LM; Ooi E; Wormald PJ
Am J Rhinol Allergy; 2009; 23(2):123-9. PubMed ID: 19401034
[TBL] [Abstract][Full Text] [Related]
19. Protection of neonatal chicks against a lethal challenge of Escherichia coli using DNA containing cytosine-phosphodiester-guanine motifs.
Gomis S; Babiuk L; Allan B; Willson P; Waters E; Ambrose N; Hecker R; Potter A
Avian Dis; 2004 Dec; 48(4):813-22. PubMed ID: 15666862
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
